176 related articles for article (PubMed ID: 17895767)
1. Contemporaneous H&E sections should be standard practice in diagnostic immunopathology.
Hoda SA; Rosen PP
Am J Surg Pathol; 2007 Oct; 31(10):1627. PubMed ID: 17895767
[No Abstract] [Full Text] [Related]
2. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.
Goldstein NS; Bassi D; Watts JC; Layfield LJ; Yaziji H; Gown AM
Am J Clin Pathol; 2001 Apr; 115(4):534-42. PubMed ID: 11293901
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic immunohistochemistry of breast epithelial lesions].
Balaton AJ; Guinebretière JM; Penault-Llorca F
Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
[TBL] [Abstract][Full Text] [Related]
4. Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.
MacGrogan G; Arnould L; de Mascarel I; Vincent-Salomon A; Penault-Llorca F; Lacroix-Triki M; Bibeau F; Baranzelli MC; Fridman V; Antoine M; Bécette V; Brouste V; Jacquemier J; Mathoulin-Pélissier S;
Histopathology; 2008 May; 52(6):689-97. PubMed ID: 18397281
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma in situ of the breast: a light microscopic and immunohistochemical study of a previously undescribed lesion.
Hayes MM; Peterse JL; Yavuz E; Vischer GH; Eusebi V
Am J Surg Pathol; 2007 Sep; 31(9):1414-9. PubMed ID: 17721198
[TBL] [Abstract][Full Text] [Related]
6. Collagenous spherulosis with lobular carcinoma in situ: a potential diagnostic pitfall.
Hill P; Cawson J
Pathology; 2007 Jun; 39(3):361-3. PubMed ID: 17558867
[No Abstract] [Full Text] [Related]
7. Distinctive biology of pleomorphic lobular carcinoma of the breast.
Moe RE; Anderson BO
J Surg Oncol; 2005 May; 90(2):47-50. PubMed ID: 15844193
[No Abstract] [Full Text] [Related]
8. [Diagnostic pitfalls in mammary pathology. Case 1. In situ ductal carcinoma of low nuclear grade, with papillary, micropapillary and cribriform architecture].
MacGrogan G
Ann Pathol; 2009 Jun; 29(3):188-93. PubMed ID: 19619824
[No Abstract] [Full Text] [Related]
9. E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.
Canas-Marques R; Schnitt SJ
Histopathology; 2016 Jan; 68(1):57-69. PubMed ID: 26768029
[TBL] [Abstract][Full Text] [Related]
10. Microinvasive carcinoma of the breast: can it be diagnosed reliably and is it clinically significant?
Hoda SA; Prasad ML; Moore A; Hoda RS; Giri D
Histopathology; 1999 Nov; 35(5):468-70. PubMed ID: 10583563
[TBL] [Abstract][Full Text] [Related]
11. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
Rabban JT; Chen YY
Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
[TBL] [Abstract][Full Text] [Related]
12. Papillary lesions of the breast: selected diagnostic and management issues.
Collins LC; Schnitt SJ
Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic carcinoma with osteoclastic giant cells of the breast: immunohistochemical differentiation between coexisting neoplastic and reactive giant cells.
Kurokawa K; Mouri Y; Asano A; Kamei K; Iwata Y; Isogai M; Saga S; Ichihara S
Pathol Int; 2009 Feb; 59(2):91-7. PubMed ID: 19154262
[TBL] [Abstract][Full Text] [Related]
14. Multi-institutional comparison of whole slide digital imaging and optical microscopy for interpretation of hematoxylin-eosin-stained breast tissue sections.
Krishnamurthy S; Mathews K; McClure S; Murray M; Gilcrease M; Albarracin C; Spinosa J; Chang B; Ho J; Holt J; Cohen A; Giri D; Garg K; Bassett RL; Liang K
Arch Pathol Lab Med; 2013 Dec; 137(12):1733-9. PubMed ID: 23947655
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions.
Moriya T; Kanomata N; Kozuka Y; Fukumoto M; Iwachido N; Hata S; Takahashi Y; Miura H; Ishida K; Watanabe M
Breast Cancer; 2009; 16(3):173-8. PubMed ID: 19475479
[TBL] [Abstract][Full Text] [Related]
16. Fortuitous diagnosis in a uterine leiomyoma of metastatic lobular carcinoma of the breast.
Liebmann RD; Jones KD; Hamid R; Lapsley M
Histopathology; 1998 Jun; 32(6):577-8. PubMed ID: 9675605
[No Abstract] [Full Text] [Related]
17. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
18. Anatomopathological analysis of sentinel and nonsentinel lymph nodes in breast cancer: hematoxylin-eosin versus immunohistochemistry.
Soares CT; Frederigue-Junior U; Luca LA
Int J Surg Pathol; 2007 Oct; 15(4):358-68. PubMed ID: 17913942
[TBL] [Abstract][Full Text] [Related]
19. Luminal B breast tumors are not HER2 positive.
Bhargava R; Dabbs DJ
Breast Cancer Res; 2008; 10(5):404; author reply 405. PubMed ID: 18831725
[No Abstract] [Full Text] [Related]
20. Enophthalmos as initial manifestation of occult, mammogram-negative carcinoma of the breast.
Shields CL; Stopyra GA; Marr BP; Moster ML; Shields JA
Ophthalmic Surg Lasers Imaging; 2004; 35(1):56-7. PubMed ID: 14750765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
